IP: Patent applications (pending) on two inventions: claiming the use of artemisinin and related compounds against cancer (humans/pets) and stabilized combinations of artemisinin/related compounds and components of coffee.

FDA: Approved Investigational New Drug (IND) for ArtemiCafé™️ Decaf, allowing for immediate start of any Phase II clinical trial against any cancer (including a cancer preventative trial).